⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27610138 | 0.97 | — | — | |
| SCHEMBL11080729 | 0.97 | — | — | |
| SCHEMBL28487733 | 0.97 | — | — | |
| Butane SCHEMBL4602907 | 0.88 | FDPS (0.40) | — | |
| SCHEMBL1516769 | 0.74 | KDM4E (0.44) | — | |
| SCHEMBL1516784 | 0.74 | KDM4E (0.44) | — | |
| SCHEMBL3397703 | 0.69 | — | — | |
| SCHEMBL9790071 | 0.69 | — | — | |
| SCHEMBL9436890 | 0.69 | — | — | |
| SCHEMBL30383 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4536217-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | Fleurir Abx LLC (US) | 2025-04-16 | — | — | EP | claimed |
| CN-118834861-A | Method for synthesizing 2-hydroxyethyl phosphonic acid by enzyme method | 中国科学院大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118834860-A | Method for synthesizing methylphosphonic acid by enzyme method | 中国科学院大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118834862-A | Method for synthesizing phosphonoacetaldehyde by enzymatic method | 中国科学院大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118725325-A | Method for improving freezing resistance of metal-organic framework and application of method in erythrocyte freezing protection | 华南理工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118415161-A | Improved erythrocyte cryoprotectant containing D-trehalose and preparation method and application thereof | 华南理工大学 | 2024-08-02 | — | — | CN | claimed |
| WO-2023239822-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | WO | claimed |
| US-20230398101-A1 | Co-agents as Therapy Against Anaerobic Pathogens | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | US | claimed |
| EP-1727814-B1 | NUCLEOSIDE ANALOGUES WITH ANTIVIRAL ACTIVITY | UNIV CATANIA (IT) | 2008-04-30 | — | — | EP | claimed |
| EP-1727814-A1 | NUCLEOSIDE ANALOGUES WITH ANTIVIRAL ACTIVITY | Universita' Degli Studi Di Catania (IT) | 2006-12-06 | — | — | EP | claimed |
| WO-2005082896-A1 | NUCLEOSIDE ANALOGUES WITH ANTIVIRAL ACTIVITY | UNIVERSITA' DEGLI STUDI DI CATANIA (IT) | 2005-09-09 | — | — | WO | claimed |
| EP-1423356-A2 | NOVEL AMINOBENZOEPHENONES | Leo Pharma A/S (DK) | 2004-06-02 | — | — | EP | claimed |
| WO-2003018535-A2 | NOVEL AMINOBENZOEPHENONES | LEO PHARMA A/S (DK) | 2003-03-06 | — | — | WO | claimed |
| EP-0344979-B1 | Alfa-adrenergic receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 1994-11-09 | — | — | EP | claimed |
| EP-0344979-A2 | Alfa-adrenergic receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1989-12-06 | — | — | EP | claimed |
| EP-0344980-A2 | Alpha-adrenergic receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1989-12-06 | — | — | EP | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4695412-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-0344982-A2 | Alpha-adrenergic receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 1989-12-06 | — | — | EP | disclosed |
| US-4879069-A | DIAGNOSIS OF CHOLESTEROL LEVEL | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1989-11-07 | — | — | US | disclosed |